Semaglutide
US$ 20.49
noom. glp 1 Noom to offer GLP-1 drug through new weight loss program GLP-1s can support change -
Description
It seems like asking someone to stay on a weekly injection indefinitely is a much harder sell
If you plan to use a GLP-1 medication in 2025, consider increasing your FSA or HSA contributions
The company announced new collaborations with Repertoire Immune Medicines for autoimmune disease programs and Seamless Therapeutics for gene editing treatments aimed at hearing loss
Akkermansia (Pasteurized Akkermansia muciniphila)
Available in-office or via telehealth